When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CELG - European advisory group back Roche's Tecentriq combo in first-line lung cancer
Celgene Corporation
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Roche's (OTCQX:RHHBY) Tecentriq (atezolizumab), combined with chemo and Celgene's (NASDAQ:CELG) Abraxane [albumin-bound paclitaxel; nab-paclitaxel], for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not have EGFR-mutant or ALK-positive NSCLC.
More news on: Roche Holding AG, Celgene Corporation, Healthcare stocks news,